Q L Lu|P Abel|C S Foster|E N Lalani - JoVE Visualize

Showing results (1-10 of 536) with videos related to

Pageof 54

Sort By:

Human Pathology|February 1, 1996

bcl-2: role in epithelial differentiation and oncogenesisQ L Lu, P Abel, C S Foster, et al.

The Journal of Pathology|February 5, 2000

Decreased HLA-A expression in prostate cancer is associated with normal allele dosage in the majority of casesQ L Lu, P Abel, S Mitchell, et al.

Molecular Pathology : MP|February 1, 1997

Expression of bcl-2 in bladder neoplasms is a cell lineage associated and p53-independent eventQ L Lu, M Laniado, P D Abel, et al.

European Urology|January 1, 1997

Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomasQ L Lu, Lalani el-N, P Abel

International Journal of Cancer|June 1, 1994

Establishment and in vivo characterization of multidrug-resistant dunning R3327 rat prostate-carcinoma cell-linesI Bashir, K Sikora, P Abel, et al.

BJU International|February 20, 2002

Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancerS S El-Sheikh, S Madaan, A Alhasso, et al.

FEBS Letters|April 1, 1996

Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145A P Stubbs, E N Lalani, G W Stamp, et al.

Journal of Clinical Pathology|May 27, 1999

Correlation between androgen receptor expression and FGF8 mRNA levels in patients with prostate cancer and benign prostatic hypertrophyQ Wang, G W Stamp, S Powell, et al.

The Biochemical Journal|March 1, 1979

Stimulation of defective Gunn-rat liver uridine diphosphate glucuronyltransferase activity in vitro by alkyl ketonesE N Lalani, B Burchell

British Journal of Urology|January 1, 1997

Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladderK S Chaudhary, Q L Lu, P D Abel, et al.

Pageof 54

Showing results (1-10 of 536) with videos related to

Sort By:

Pageof 54

Human Pathology|February 1, 1996

bcl-2: role in epithelial differentiation and oncogenesisQ L Lu, P Abel, C S Foster, et al.

The Journal of Pathology|February 5, 2000

Decreased HLA-A expression in prostate cancer is associated with normal allele dosage in the majority of casesQ L Lu, P Abel, S Mitchell, et al.

Molecular Pathology : MP|February 1, 1997

Expression of bcl-2 in bladder neoplasms is a cell lineage associated and p53-independent eventQ L Lu, M Laniado, P D Abel, et al.

European Urology|January 1, 1997

Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomasQ L Lu, Lalani el-N, P Abel

International Journal of Cancer|June 1, 1994

Establishment and in vivo characterization of multidrug-resistant dunning R3327 rat prostate-carcinoma cell-linesI Bashir, K Sikora, P Abel, et al.

BJU International|February 20, 2002

Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancerS S El-Sheikh, S Madaan, A Alhasso, et al.

FEBS Letters|April 1, 1996

Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145A P Stubbs, E N Lalani, G W Stamp, et al.

Journal of Clinical Pathology|May 27, 1999

Correlation between androgen receptor expression and FGF8 mRNA levels in patients with prostate cancer and benign prostatic hypertrophyQ Wang, G W Stamp, S Powell, et al.

The Biochemical Journal|March 1, 1979

Stimulation of defective Gunn-rat liver uridine diphosphate glucuronyltransferase activity in vitro by alkyl ketonesE N Lalani, B Burchell

British Journal of Urology|January 1, 1997

Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladderK S Chaudhary, Q L Lu, P D Abel, et al.

Pageof 54